Foghorn Therapeutics FHTX
NASDAQ FHTX
$2.93 -0.64 (-17.93%)
As of: Oct 1, 2026 · 3:59 PM EDT

Foghorn Therapeutics (FHTX) Non-Current Deffered Revenue (2020 - 2026)

Updated

Foghorn Therapeutics' Non-Current Deffered Revenue came in at $193.22 million for Q2 2026, down 6.6% from $206.83 million a year earlier and down 0.2% from the prior quarter.

Analysis

Foghorn Therapeutics (FHTX) Non-Current Deffered Revenue (2020 - 2026) Analysis & Trends

At the end of FY2025, Foghorn Therapeutics' Non-Current Deffered Revenue was $205.96 million, down 12.2% from FY2024.

  • Non-Current Deffered Revenue has declined in each of the last four years, though with a five-year compound annual growth rate of 75.0% (FY2020 to FY2025).
  • Going back by year, Non-Current Deffered Revenue was $234.46 million in FY2024 (-12.6%), $268.12 million in FY2023 (-11.8%), $304 million in FY2022 (-5.8%) and $322.73 million in FY2021.
  • The five-year range for quarterly Non-Current Deffered Revenue is $12.69 million (Q3 2021) to $322.73 million (Q4 2021).
  • Year-over-year, Non-Current Deffered Revenue has declined for 15 consecutive quarters, with an average decline of 14.3% over the last eight quarters.
  • Over the past five years, the year-over-year decline in Non-Current Deffered Revenue ranged from 3.3% (Q3 2021) to 22.6% (Q3 2025).
  • Business Quant data shows FHTX's Non-Current Deffered Revenue at $193.59 million (Q1 2026), $205.96 million (Q4 2025) and $193.1 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Foghorn Therapeutics 209.61 Mn -116.34 Mn - 193.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 193.22 Mn
Mar 31, 2026 193.59 Mn
Dec 31, 2025 205.96 Mn
Sep 30, 2025 193.10 Mn
Jun 30, 2025 206.83 Mn
Mar 31, 2025 222.44 Mn
Dec 31, 2024 234.46 Mn
Sep 30, 2024 249.54 Mn
Jun 30, 2024 259.50 Mn
Mar 31, 2024 266.11 Mn
Dec 31, 2023 268.12 Mn
Sep 30, 2023 280.09 Mn
Jun 30, 2023 292.02 Mn
Mar 31, 2023 298.18 Mn
Dec 31, 2022 304.00 Mn
Sep 30, 2022 307.84 Mn
Jun 30, 2022 312.07 Mn
Mar 31, 2022 317.07 Mn
Dec 31, 2021 322.73 Mn
Sep 30, 2021 12.69 Mn
API Access

Foghorn Therapeutics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=FHTX&period=max&api_key=YOUR_API_KEY